Last 12 months
Inside the activity.
0 purchase rows · 38 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 22 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 08, 2017 Filed Sep 12, 2017 20:02 UTC |
Rudelius Robert JamesDirector
|
Exercise / conversionDirector Stock Option (right to purchase) · Derivative | 20,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001179110-17-012194 · edgar.xml · derivative · entry 4 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2017-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2017 Filed Sep 12, 2017 20:02 UTC |
Rudelius Robert JamesDirector
|
Tax withholdingCommon Stock | 3,857 | $18.15 | $70,004.55 |
DisclosureSEC source: 0001179110-17-012194 · edgar.xml · nonDerivative · entry 2 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,416 F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 20,000 shares by means of a cashless exercise. A cashless exercise is a method of exercising a stock option in which the option holder pays the exercise price using shares the reporting person would have received pursuant to the option exercise. As a result of this cashless exercise, the Reporting Person, on a net basis, acquired ownership of an additional 16,143 shares of common stock. Read SEC document |
| September 08, 2017 Filed Sep 12, 2017 20:02 UTC |
Rudelius Robert JamesDirector
|
Exercise / conversionCommon Stock | 20,000 | $3.50 | $70,000.00 |
DisclosureSEC source: 0001179110-17-012194 · edgar.xml · nonDerivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 20,000 shares by means of a cashless exercise. A cashless exercise is a method of exercising a stock option in which the option holder pays the exercise price using shares the reporting person would have received pursuant to the option exercise. As a result of this cashless exercise, the Reporting Person, on a net basis, acquired ownership of an additional 16,143 shares of common stock. Read SEC document |
| August 27, 2017 Filed Aug 29, 2017 20:58 UTC |
Freitag Gregory GeneDirector · General Counsel & SVP BD
|
Exercise / conversionEmployee Stock Option (right to purchase) · Derivative | 23,000 | $0.00 Strike: $2.74 | $0.00 |
DisclosureSEC source: 0001179110-17-011880 · edgar.xml · derivative · entry 3 Freitag Gregory Gene · CIK 0001492710 · Director · General Counsel & SVP BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,000 Underlying: Common Stock · 23,000 shares Expires 2018-12-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2017 Filed Aug 29, 2017 20:58 UTC |
Freitag Gregory GeneDirector · General Counsel & SVP BD
|
Tax withholdingCommon Stock | 3,785 | $16.65 | $63,020.25 |
DisclosureSEC source: 0001179110-17-011880 · edgar.xml · nonDerivative · entry 2 Freitag Gregory Gene · CIK 0001492710 · Director · General Counsel & SVP BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,116 F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 23,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 19,215 shares of common stock. Read SEC document |
| August 27, 2017 Filed Aug 29, 2017 20:58 UTC |
Freitag Gregory GeneDirector · General Counsel & SVP BD
|
Exercise / conversionCommon Stock | 23,000 | $2.74 | $63,020.00 |
DisclosureSEC source: 0001179110-17-011880 · edgar.xml · nonDerivative · entry 1 Freitag Gregory Gene · CIK 0001492710 · Director · General Counsel & SVP BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 23,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 19,215 shares of common stock. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 21:10 UTC |
MCCARREY SHAWN FSVP Sales
|
Tax withholdingCommon Stock | 2,383 | $15.15 | $36,102.45 |
DisclosureSEC source: 0001179110-17-011153 · edgar.xml · nonDerivative · entry 2 MCCARREY SHAWN F · CIK 0001195924 · SVP Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,167 Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 21:10 UTC |
MCCARREY SHAWN FSVP Sales
|
GrantCommon Stock | 7,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-011153 · edgar.xml · nonDerivative · entry 1 MCCARREY SHAWN F · CIK 0001195924 · SVP Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,550 F1 · shares: Represents shares of common stock that have vested and settled in accordance with that certain PSU Agreement granted to the reporting person on December 29, 2016. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 20:20 UTC |
Gingrich Jon S.Chief Commercial Officer
|
GrantEmployee Stock Option (right to purchase) · Derivative | 115,000 | $0.00 Strike: $16.85 | $0.00 |
DisclosureSEC source: 0001179110-17-010417 · edgar.xml · derivative · entry 1 Gingrich Jon S. · CIK 0001711638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock · 115,000 shares Expires 2027-07-17 F1 · derivative.exercise_date: All shares of Common Stock underlying the employee stock option will be fully vested on July 17, 2021 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on July 17, 2018 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 20:49 UTC |
Wendell Amy McBrideDirector
|
GrantStock Option (right to purchase) · Derivative | 15,000 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001179110-17-008551 · edgar.xml · derivative · entry 1 Wendell Amy McBride · CIK 0001400568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-01 F1 · derivative.exercise_date: Non-qualified stock option grant for service as Director on Company's Board of directors. Options vest in equal installments every three months for the first nine months, with the final installment vesting on the date of the then current annual meeting. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 20:49 UTC |
Rudelius Robert JamesDirector
|
GrantStock Option (right to purchase) · Derivative | 15,000 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001179110-17-008550 · edgar.xml · derivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-01 F1 · derivative.exercise_date: Non-qualified stock option grant for service as Director on Company's Board of directors. Options vest in equal installments every three months for the first nine months, with the final installment vesting on the date of the then current annual meeting. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 20:48 UTC |
Gold Mark StephenDirector
|
GrantStock Option (right to purchase) · Derivative | 15,000 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001179110-17-008549 · edgar.xml · derivative · entry 1 Gold Mark Stephen · CIK 0001531332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-01 F1 · derivative.exercise_date: Non-qualified stock option grant for service as Director on Company's Board of directors. Options vest in equal installments every three months for the first nine months, with the final installment vesting on the date of the then current annual meeting. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 20:48 UTC |
Grooms Jamie MarkDirector
|
GrantStock Option (right to purchase) · Derivative | 15,000 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001179110-17-008548 · edgar.xml · derivative · entry 1 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-01 F1 · derivative.exercise_date: Non-qualified stock option grant for service as Director on Company's Board of directors. Options vest in equal installments every three months for the first nine months, with the final installment vesting on the date of the then current annual meeting. Read SEC document |
| June 01, 2017 Filed Jun 8, 2017 17:39 UTC |
NEELS GUIDO JDirector
|
GrantStock Option (right to purchase) · Derivative | 15,000 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001179110-17-008753 · edgar.xml · derivative · entry 1 NEELS GUIDO J · CIK 0001222362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-01 F1 · derivative.exercise_date: Non-qualified stock option grant for service as Director on Company's Board of directors. Options vest in equal installments every three months for the first nine months, with the final installment vesting on the date of the then current annual meeting. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 17:51 UTC |
Gold Mark StephenDirector
|
Exercise / conversionStock Option (right to purchase) · Derivative | 5,000 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001179110-17-008297 · edgar.xml · derivative · entry 2 Gold Mark Stephen · CIK 0001531332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2026-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 17:51 UTC |
Gold Mark StephenDirector
|
Exercise / conversionCommon Stock | 5,000 | $8.95 | $44,750.00 |
DisclosureSEC source: 0001179110-17-008297 · edgar.xml · nonDerivative · entry 1 Gold Mark Stephen · CIK 0001531332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,248 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The shares of common stock for Dr. Gold include 202,761 shares held jointly by Dr. Gold and his wife, indirect ownership of 20,000 shares held by Dr. Gold's spouse and indirect ownership of 122,487 shares held by MJSK, Ltd., a decedent investment trust held by Dr. Gold's family. F1 · ownership.direct: The shares of common stock for Dr. Gold include 202,761 shares held jointly by Dr. Gold and his wife, indirect ownership of 20,000 shares held by Dr. Gold's spouse and indirect ownership of 122,487 shares held by MJSK, Ltd., a decedent investment trust held by Dr. Gold's family. Read SEC document |
| May 22, 2017 Filed May 26, 2017 20:24 UTC |
Gold Mark StephenDirector
|
Exercise / conversionStock Option (right to purchase) · Derivative | 15,000 | $0.00 Strike: $4.81 | $0.00 |
DisclosureSEC source: 0001179110-17-008083 · edgar.xml · derivative · entry 2 Gold Mark Stephen · CIK 0001531332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2024-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2017 Filed May 26, 2017 20:24 UTC |
Gold Mark StephenDirector
|
Exercise / conversionCommon Stock | 15,000 | $4.81 | $72,150.00 |
DisclosureSEC source: 0001179110-17-008083 · edgar.xml · nonDerivative · entry 1 Gold Mark Stephen · CIK 0001531332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,248 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The shares of common stock for Dr. Gold include 197,761 shares held jointly by Dr. Gold and his wife, indirect ownership of 20,000 shares held by Dr. Gold's spouse and indirect ownership of 122,487 shares held by MJSK, Ltd., a decedent investment trust held by Dr. Gold's family. F1 · ownership.direct: The shares of common stock for Dr. Gold include 197,761 shares held jointly by Dr. Gold and his wife, indirect ownership of 20,000 shares held by Dr. Gold's spouse and indirect ownership of 122,487 shares held by MJSK, Ltd., a decedent investment trust held by Dr. Gold's family. Read SEC document |
| March 14, 2017 Filed Mar 14, 2017 23:32 UTC |
DeVinney Erick WayneVP, Clinical&Translational Sc
|
Exercise / conversionEmployee Stock Option (right to purchase) · Derivative | 359 | $0.00 Strike: $0.27 | $0.00 |
DisclosureSEC source: 0001179110-17-004610 · edgar.xml · derivative · entry 4 DeVinney Erick Wayne · CIK 0001595972 · VP, Clinical&Translational Sc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 359 shares Expires 2017-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2017 Filed Mar 14, 2017 23:32 UTC |
DeVinney Erick WayneVP, Clinical&Translational Sc
|
Exercise / conversionEmployee Stock Option (right to purchase) · Derivative | 4,659 | $0.00 Strike: $0.27 | $0.00 |
DisclosureSEC source: 0001179110-17-004610 · edgar.xml · derivative · entry 3 DeVinney Erick Wayne · CIK 0001595972 · VP, Clinical&Translational Sc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,659 shares Expires 2017-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2017 Filed Mar 14, 2017 23:32 UTC |
DeVinney Erick WayneVP, Clinical&Translational Sc
|
Exercise / conversionCommon Stock | 359 | $0.27 | $96.93 |
DisclosureSEC source: 0001179110-17-004610 · edgar.xml · nonDerivative · entry 2 DeVinney Erick Wayne · CIK 0001595972 · VP, Clinical&Translational Sc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2017 Filed Mar 14, 2017 23:32 UTC |
DeVinney Erick WayneVP, Clinical&Translational Sc
|
Exercise / conversionCommon Stock | 4,659 | $0.27 | $1,257.93 |
DisclosureSEC source: 0001179110-17-004610 · edgar.xml · nonDerivative · entry 1 DeVinney Erick Wayne · CIK 0001595972 · VP, Clinical&Translational Sc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,659 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2017 Filed Mar 14, 2017 23:32 UTC |
Donovan Michael PatrickVP Operations
|
Exercise / conversionEmployee Stock Option (right to purchase) · Derivative | 5,000 | $0.00 Strike: $2.74 | $0.00 |
DisclosureSEC source: 0001179110-17-004609 · edgar.xml · derivative · entry 4 Donovan Michael Patrick · CIK 0001653918 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 35,000 shares Expires 2018-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2017 Filed Mar 14, 2017 23:32 UTC |
Donovan Michael PatrickVP Operations
|
Exercise / conversionEmployee Stock Option (right to purchase) · Derivative | 4,659 | $0.00 Strike: $0.27 | $0.00 |
DisclosureSEC source: 0001179110-17-004609 · edgar.xml · derivative · entry 3 Donovan Michael Patrick · CIK 0001653918 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,659 shares Expires 2018-01-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2017 Filed Mar 14, 2017 23:32 UTC |
Donovan Michael PatrickVP Operations
|
Exercise / conversionCommon Stock | 5,000 | $2.74 | $13,700.00 |
DisclosureSEC source: 0001179110-17-004609 · edgar.xml · nonDerivative · entry 2 Donovan Michael Patrick · CIK 0001653918 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,659 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2017 Filed Mar 14, 2017 23:32 UTC |
Donovan Michael PatrickVP Operations
|
Exercise / conversionCommon Stock | 4,659 | $0.27 | $1,257.93 |
DisclosureSEC source: 0001179110-17-004609 · edgar.xml · nonDerivative · entry 1 Donovan Michael Patrick · CIK 0001653918 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,659 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 30, 2016 Filed Mar 14, 2017 23:31 UTC |
Freitag Gregory GeneDirector · General Counsel & SVP BD
|
Exercise / conversionCommon Stock | 23,000 | $2.74 | $63,020.00 |
DisclosureSEC source: 0001179110-17-004608 · edgar.xml · nonDerivative · entry 1 Freitag Gregory Gene · CIK 0001492710 · Director · General Counsel & SVP BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 29, 2016 Filed Jan 3, 2017 22:23 UTC |
Zaderej Karen L.Director · CEO
|
GrantEmployee Stock Option (right to purchase) · Derivative | 209,500 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001179110-17-000101 · edgar.xml · derivative · entry 2 Zaderej Karen L. · CIK 0001530968 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,500 Underlying: Common Stock · 209,500 shares Expires 2026-12-29 F2 · derivative.exercise_date: All shares of Common Stock underlying the employee stock option will be fully vested on December 29, 2020 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on December 29, 2017 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter. Read SEC document |
| December 29, 2016 Filed Jan 3, 2017 22:23 UTC |
Zaderej Karen L.Director · CEO
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-000101 · edgar.xml · nonDerivative · entry 1 Zaderej Karen L. · CIK 0001530968 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,147 F1 · shares: Represents shares underlying retention-based restricted stock units, all of which shall become vested on January 1, 2020 so long as the reporting person's employment is continuous from December 29, 2016 through January 1, 2020. Read SEC document |
| December 29, 2016 Filed Jan 3, 2017 21:46 UTC |
Grooms Jamie MarkDirector
|
GrantStock Option (right to purchase) · Derivative | 5,000 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001179110-17-000085 · edgar.xml · derivative · entry 1 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2026-12-29 F1 · derivative.exercise_date: Non-qualified stock option grant for service as Director on Company's Board of directors. Vesting is 100% upon the director's re-election to the Company's Board of Directors at the 2017 Annual Meeting of Shareholders. Read SEC document |
| December 29, 2016 Filed Jan 3, 2017 22:06 UTC |
NEELS GUIDO JDirector
|
GrantStock Option (right to purchase) · Derivative | 5,000 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001179110-17-000096 · edgar.xml · derivative · entry 1 NEELS GUIDO J · CIK 0001222362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2026-12-29 F1 · derivative.exercise_date: Non-qualified stock option grant for service as Director on Company's Board of directors. Vesting is 100% upon the director's re-election to the Company's Board of Directors at the 2017 Annual Meeting of Shareholders. Read SEC document |
| December 29, 2016 Filed Jan 3, 2017 21:43 UTC |
Leach KevinVice President Marketing
|
GrantEmployee Stock Option (right to purchase) · Derivative | 45,000 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001179110-17-000078 · edgar.xml · derivative · entry 1 Leach Kevin · CIK 0001668805 · Vice President Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2026-12-29 F1 · derivative.exercise_date: All shares of Common Stock underlying the employee stock option will be fully vested on December 29, 2020(4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on December 29, 2017(12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter. Read SEC document |
| December 29, 2016 Filed Jan 3, 2017 21:41 UTC |
Rudelius Robert JamesDirector
|
GrantStock Option (right to purchase) · Derivative | 5,000 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001179110-17-000075 · edgar.xml · derivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2026-12-29 F1 · derivative.exercise_date: Non-qualified stock option grant for service as Director on Company's Board of directors. Vesting is 100% upon the director's re-election to the Company's Board of Directors at the 2017 Annual Meeting of Shareholders. Read SEC document |
| December 29, 2016 Filed Jan 3, 2017 21:40 UTC |
MARIANI PETER JChief Financial Officer
|
GrantEmployee Stock Option (right to purchase) · Derivative | 110,000 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001179110-17-000074 · edgar.xml · derivative · entry 1 MARIANI PETER J · CIK 0001222357 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2026-12-29 F1 · derivative.exercise_date: All shares of Common Stock underlying the employee stock option will be fully vested on December 29, 2020(4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on December 29, 2017(12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter. Read SEC document |
| December 29, 2016 Filed Jan 3, 2017 22:14 UTC |
Freitag Gregory GeneDirector · General Counsel & SVP BD
|
GrantEmployee Stock Option (right to purchase) · Derivative | 50,000 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001179110-17-000100 · edgar.xml · derivative · entry 1 Freitag Gregory Gene · CIK 0001492710 · Director · General Counsel & SVP BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2026-12-29 F1 · derivative.exercise_date: All shares of Common Stock underlying the employee stock option will be fully vested on December 29, 2020(4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on December 29, 2017(12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter. Read SEC document |
| December 29, 2016 Filed Jan 3, 2017 21:46 UTC |
Wendell Amy McBrideDirector
|
GrantStock Option (right to purchase) · Derivative | 5,000 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001179110-17-000088 · edgar.xml · derivative · entry 1 Wendell Amy McBride · CIK 0001400568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2026-12-29 F1 · derivative.exercise_date: Non-qualified stock option grant for service as Director on Company's Board of directors. Vesting is 100% upon the director's re-election to the Company's Board of Directors at the 2017 Annual Meeting of Shareholders. Read SEC document |
| December 29, 2016 Filed Jan 3, 2017 21:46 UTC |
Gold Mark StephenDirector
|
GrantStock Option (right to purchase) · Derivative | 5,000 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001179110-17-000086 · edgar.xml · derivative · entry 1 Gold Mark Stephen · CIK 0001531332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2026-12-29 F1 · derivative.exercise_date: Non-qualified stock option grant for service as Director on Company's Board of directors. Vesting is 100% upon the director's re-election to the Company's Board of Directors at the 2017 Annual Meeting of Shareholders. Read SEC document |
| December 29, 2016 Filed Jan 3, 2017 21:45 UTC |
DeVinney Erick WayneVP, Clinical&Translational Sc
|
GrantEmployee Stock Option (right to purchase) · Derivative | 50,000 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001179110-17-000084 · edgar.xml · derivative · entry 1 DeVinney Erick Wayne · CIK 0001595972 · VP, Clinical&Translational Sc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2026-12-29 F1 · derivative.exercise_date: All shares of Common Stock underlying the employee stock option will be fully vested on December 29, 2020(4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on December 29, 2017(12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter. Read SEC document |
| December 29, 2016 Filed Jan 3, 2017 21:45 UTC |
Donovan Michael PatrickVP Operations
|
GrantEmployee Stock Option (right to purchase) · Derivative | 25,000 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001179110-17-000083 · edgar.xml · derivative · entry 1 Donovan Michael Patrick · CIK 0001653918 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2026-12-29 F1 · derivative.exercise_date: All shares of Common Stock underlying the employee stock option will be fully vested on December 29, 2020(4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on December 29, 2017(12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter. Read SEC document |
| December 29, 2016 Filed Jan 3, 2017 21:44 UTC |
Hansen David KChief Accounting Officer
|
GrantEmployee Stock Option (right to purchase) · Derivative | 25,000 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001179110-17-000081 · edgar.xml · derivative · entry 1 Hansen David K · CIK 0001362545 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2026-12-29 F1 · derivative.exercise_date: All shares of Common Stock underlying the employee stock option will be fully vested on December 29, 2020(4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on December 29, 2017(12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter. Read SEC document |
| December 29, 2016 Filed Jan 3, 2017 21:44 UTC |
MCCARREY SHAWN FSVP Sales
|
GrantEmployee Stock Option (right to purchase) · Derivative | 50,000 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001179110-17-000080 · edgar.xml · derivative · entry 1 MCCARREY SHAWN F · CIK 0001195924 · SVP Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2026-12-29 F1 · derivative.exercise_date: All shares of Common Stock underlying the employee stock option will be fully vested on December 29, 2020(4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on December 29, 2017(12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter. Read SEC document |
| December 29, 2016 Filed Jan 3, 2017 21:43 UTC |
Friedman Mark LouisVP,Regulatory & Quality
|
GrantEmployee Stock Option (right to purchase) · Derivative | 25,000 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001179110-17-000079 · edgar.xml · derivative · entry 1 Friedman Mark Louis · CIK 0001531023 · VP,Regulatory & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2026-12-29 F1 · derivative.exercise_date: All shares of Common Stock underlying the employee stock option will be fully vested on December 29, 2020(4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on December 29, 2017(12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter. Read SEC document |
| December 29, 2016 Filed Jan 3, 2017 21:41 UTC |
Rudelius Robert JamesDirector
|
GrantStock Option (right to purchase) · Derivative | 5,000 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001179110-17-000076 · edgar.xml · derivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2026-12-29 F1 · derivative.exercise_date: Non-qualified stock option grant for service as Director on Company's Board of directors. Vesting is 100% upon the director's re-election to the Company's Board of Directors at the 2017 Annual Meeting of Shareholders. Read SEC document |
| October 07, 2016 Filed Oct 14, 2016 19:14 UTC |
Leach KevinVice President Marketing
|
PurchaseCommon Stock | 2,000 | $7.50 | $15,000.00 |
DisclosureSEC source: 0001179110-16-030714 · edgar.xml · nonDerivative · entry 1 Leach Kevin · CIK 0001668805 · Vice President Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · shares: The reporting person purchased these shares in his individual capacity and not through any directed share or other formal program in connection with an underwritten registered public offering of the Company. On October 7, 2016, the trade date for the public offering, the closing sale price reported by NASDAQ was $9.15 per share. The public offering closed on October 13, 2016 and the closing sale price reported by NASDAQ on such date was $8.72 per share. F1 · price: The reporting person purchased these shares in his individual capacity and not through any directed share or other formal program in connection with an underwritten registered public offering of the Company. On October 7, 2016, the trade date for the public offering, the closing sale price reported by NASDAQ was $9.15 per share. The public offering closed on October 13, 2016 and the closing sale price reported by NASDAQ on such date was $8.72 per share. Read SEC document |
| October 07, 2016 Filed Oct 14, 2016 19:36 UTC |
Wendell Amy McBrideDirector
|
PurchaseCommon Stock | 13,333 | $7.50 | $99,997.50 |
DisclosureSEC source: 0001179110-16-030715 · edgar.xml · nonDerivative · entry 1 Wendell Amy McBride · CIK 0001400568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,333 F1 · shares: The reporting person purchased these shares in her individual capacity and not through any directed share or other formal program in connection with an underwritten registered public offering of the Company. On October 7, 2016, the trade date for the public offering, the closing sale price reported by NASDAQ was $9.15 per share. The public offering closed on October 13, 2016 and the closing sale price reported by NASDAQ on such date was $8.72 per share. F1 · price: The reporting person purchased these shares in her individual capacity and not through any directed share or other formal program in connection with an underwritten registered public offering of the Company. On October 7, 2016, the trade date for the public offering, the closing sale price reported by NASDAQ was $9.15 per share. The public offering closed on October 13, 2016 and the closing sale price reported by NASDAQ on such date was $8.72 per share. Read SEC document |
| October 07, 2016 Filed Oct 14, 2016 19:13 UTC |
MARIANI PETER JChief Financial Officer
|
PurchaseCommon Stock | 3,333 | $7.50 | $24,997.50 |
DisclosureSEC source: 0001179110-16-030713 · edgar.xml · nonDerivative · entry 1 MARIANI PETER J · CIK 0001222357 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,333 F1 · shares: The reporting person purchased these shares in his individual capacity and not through any directed share or other formal program in connection with an underwritten registered public offering of the Company. On October 7, 2016, the trade date for the public offering, the closing sale price reported by NASDAQ was $9.15 per share. The public offering closed on October 13, 2016 and the closing sale price reported by NASDAQ on such date was $8.72 per share. F1 · price: The reporting person purchased these shares in his individual capacity and not through any directed share or other formal program in connection with an underwritten registered public offering of the Company. On October 7, 2016, the trade date for the public offering, the closing sale price reported by NASDAQ was $9.15 per share. The public offering closed on October 13, 2016 and the closing sale price reported by NASDAQ on such date was $8.72 per share. Read SEC document |
| October 07, 2016 Filed Oct 14, 2016 17:37 UTC |
Zaderej Karen L.Director · CEO
|
PurchaseCommon Stock | 10,000 | $7.50 | $75,000.00 |
DisclosureSEC source: 0001179110-16-030705 · edgar.xml · nonDerivative · entry 1 Zaderej Karen L. · CIK 0001530968 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,147 F1 · shares: The reporting person purchased these shares in her individual capacity and not through any directed share or other formal program in connection with an underwritten registered public offering of the Company. On October 7, 2016, the trade date for the public offering, the closing sale price reported by NASDAQ was $9.15 per share. The public offering closed on October 13, 2016 and the closing sale price reported by NASDAQ on such date was $8.72 per share. F1 · price: The reporting person purchased these shares in her individual capacity and not through any directed share or other formal program in connection with an underwritten registered public offering of the Company. On October 7, 2016, the trade date for the public offering, the closing sale price reported by NASDAQ was $9.15 per share. The public offering closed on October 13, 2016 and the closing sale price reported by NASDAQ on such date was $8.72 per share. Read SEC document |
| October 07, 2016 Filed Oct 14, 2016 17:37 UTC | PurchaseCommon Stock | 4,000 | $7.50 | $30,000.00 |
DisclosureSEC source: 0001179110-16-030704 · edgar.xml · nonDerivative · entry 1 Engels John P · CIK 0001530917 · VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,425 F1 · shares: The reporting person purchased these shares in his individual capacity and not through any directed share or other formal program in connection with an underwritten registered public offering of the Company. On October 7, 2016, the trade date for the public offering, the closing sale price reported by NASDAQ was $9.15 per share. The public offering closed on October 13, 2016 and the closing sale price reported by NASDAQ on such date was $8.72 per share. F1 · price: The reporting person purchased these shares in his individual capacity and not through any directed share or other formal program in connection with an underwritten registered public offering of the Company. On October 7, 2016, the trade date for the public offering, the closing sale price reported by NASDAQ was $9.15 per share. The public offering closed on October 13, 2016 and the closing sale price reported by NASDAQ on such date was $8.72 per share. Read SEC document |
|
| September 16, 2016 Filed Oct 13, 2016 16:10 UTC |
Wendell Amy McBrideDirector
|
GrantStock Option (right to purchase) · Derivative | 3,750 | $8.57 Strike: $8.57 | $32,137.50 |
DisclosureSEC source: 0001179110-16-030674 · edgar.xml · derivative · entry 2 Wendell Amy McBride · CIK 0001400568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 3,750 shares Expires 2023-09-16 F2 · derivative.exercise_date: Annual option grant for director of Issuer's Board of Directors, pro-rated for joining Board of Directors during annual period. Option vests as to all shares December 28, 2016 in conformity with vesting for such annual director grants. Read SEC document |
| September 16, 2016 Filed Oct 13, 2016 16:10 UTC |
Wendell Amy McBrideDirector
|
GrantStock Option (right to purchase) · Derivative | 25,000 | $0.00 Strike: $8.57 | $0.00 |
DisclosureSEC source: 0001179110-16-030674 · edgar.xml · derivative · entry 1 Wendell Amy McBride · CIK 0001400568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2023-09-16 F1 · derivative.exercise_date: Option grant for joining the Issuer's Board of Directors. Options vest quarterly as to 12.5% of total share amount beginning with the first vesting date on December 16, 2016 and becoming fully vested September 16, 2018 (two years after grant). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.